← FDA ENFORCEMENT
D-0242-2024Class I

The Procter & Gamble Company

Recalling firm
The Procter & Gamble Company
Product type
Drug
Status
Terminated
Report date
2024-01-24
Distribution
Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
Firm state
OH
Product quantity
unknown
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Chemical contamination: presence of benzene

Product description

Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g), NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 each can Net Wt. 6OZ (170g), NDC: 37000-134-01, UPC 0 37000 58690 6; Distr. by: Procter & Gamble, Cincinnati, OH 45202

Code / lot info

Lot #: (a &b) 00701458SJ, 00861458SA, 00871458SA, Exp 1/28/2022; 00921458SK, Exp 3/31/2022; 01701458SJ, 01711458SE, Exp 5/31/2022; 03431458SA, 03441458SA, 03531458SM, Exp 11/30/2022; 10681458SJ, 10691458SA, 10701458SA, 10781458SE, 10811458SJ, Exp 2/28/2023; 11701458SH, 11711458SH, 11721458SG, Exp 5/31/2023; 12181458SD, Exp 7/31/23; 12631458SH,12641458SB, 12651458SE, Exp 8/31/23; 10301458SA,Exp 12/31/22; 10921458SJ, 10931458SA, 11191458SJ, Exp 3/31/23; 11251458SB, 11421458SM, 11431458SB, Exp 4/30/2023; 11701458SH, 11711458SB, Exp 5/31/2023; 12101458SJ, 12121458SJ, Exp 6/30/2023 (c) 11711458SB, Exp 5/31/2023

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.